Miraculins

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Miraculins today said that it has successfully completed a two-part ISO certification audit conducted by the BSI Group.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Miraculins yesterday said that it has received a C$1 million (US$986,000) non-convertible secured loan from Gretchen Ross.

The company said that if all warrants are exercised on or before expiration of the early exercise period, Miraculins expects to receive gross proceeds of around C$780,000.

Bloom Burton will provide financial modeling, an assessment of financing options, an evaluation of partnership opportunities, and other services.

The biomarker-based diagnostics firm sold 10.2 million units at C$.05 each.

The biomarker-based diagnostics firm will use the placement funding for R&D and corporate purposes.

Inverness, through its Biosite division, will develop and evaluate tests using Miraculins' panel of 35 biomarkers for placenta development and preeclampsia.

Miraculins will work with the Israel-based firm on a program to develop biomarker-based diagnostics for determining preeclampsia risk.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.